Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104818848 | 10481884 | 8 | F | 20160707 | 20140929 | 20160712 | EXP | US-ELI_LILLY_AND_COMPANY-US201012000674 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160712 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104818848 | 10481884 | 1 | PS | ZYPREXA | OLANZAPINE | 1 | Oral | 5MG, DAILY | N | U | 20592 | 5 | MG | TABLET | QD | ||||
| 104818848 | 10481884 | 2 | SS | ZYPREXA | OLANZAPINE | 1 | Oral | 2.5 MG, DAILY (1/D) | N | U | 20592 | 2.5 | MG | TABLET | QD | ||||
| 104818848 | 10481884 | 3 | SS | ZYPREXA | OLANZAPINE | 1 | N | U | 20592 | TABLET | |||||||||
| 104818848 | 10481884 | 4 | SS | ZYPREXA | OLANZAPINE | 1 | N | U | 20592 | TABLET | |||||||||
| 104818848 | 10481884 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 104818848 | 10481884 | 6 | C | STELAZINE | TRIFLUOPERAZINE HYDROCHLORIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104818848 | 10481884 | 1 | Schizoaffective disorder |
| 104818848 | 10481884 | 2 | Psychotic disorder |
| 104818848 | 10481884 | 3 | Bipolar I disorder |
| 104818848 | 10481884 | 4 | Parkinson's disease |
| 104818848 | 10481884 | 5 | Product used for unknown indication |
| 104818848 | 10481884 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104818848 | 10481884 | LT |
| 104818848 | 10481884 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104818848 | 10481884 | Amnesia | |
| 104818848 | 10481884 | Balance disorder | |
| 104818848 | 10481884 | Confusional state | |
| 104818848 | 10481884 | Deafness | |
| 104818848 | 10481884 | Delirium | |
| 104818848 | 10481884 | Diarrhoea | |
| 104818848 | 10481884 | Dizziness | |
| 104818848 | 10481884 | Dyslexia | |
| 104818848 | 10481884 | Dyslogia | |
| 104818848 | 10481884 | Dysphagia | |
| 104818848 | 10481884 | Ear disorder | |
| 104818848 | 10481884 | Insomnia | |
| 104818848 | 10481884 | Intelligence test abnormal | |
| 104818848 | 10481884 | Irritability | |
| 104818848 | 10481884 | Quality of life decreased | |
| 104818848 | 10481884 | Road traffic accident | |
| 104818848 | 10481884 | Stress | |
| 104818848 | 10481884 | Thinking abnormal | |
| 104818848 | 10481884 | Tinnitus | |
| 104818848 | 10481884 | Type 2 diabetes mellitus | |
| 104818848 | 10481884 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104818848 | 10481884 | 1 | 1996 | 20080917 | 0 | |
| 104818848 | 10481884 | 2 | 20080918 | 201201 | 0 |